Clinical Trial: LC-Plasma for Preventing URTIs and Reducing Symptoms

U.S., Feb. 15 -- ClinicalTrials.gov registry received information related to the study (NCT06827327) titled 'LC-Plasma for Preventing URTIs and Reducing Symptoms' on Feb. 10.

Brief Summary: The goal of this study is to evaluate the efficacy of the LC-Plasma in preventing upper respiratory tract infections (URTIs) in healthy volunteers. Researchers will compare LC-Plasma to placebo to see if LC-Plasma prevents URTIs. Participants will take a tablet containing LC-Plasma or placebo daily for 24 weeks.

Study Start Date: March, 2025

Study Type: INTERVENTIONAL

Condition: Healthy Volunteer URTI

Intervention: DIETARY_SUPPLEMENT: LC-Plasma

1 tablet containing 50mg LC-Plasma is taken daily for 24 weeks

OTHER: Placebo

1 tablet containing 50m...